List of Tables
Table 1. Drugs for Osteoarthritis Pain Market Trends
Table 2. Drugs for Osteoarthritis Pain Market Drivers & Opportunity
Table 3. Drugs for Osteoarthritis Pain Market Challenges
Table 4. Drugs for Osteoarthritis Pain Market Restraints
Table 5. Global Drugs for Osteoarthritis Pain Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Drugs for Osteoarthritis Pain Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Drugs for Osteoarthritis Pain Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Drugs for Osteoarthritis Pain Product Type
Table 9. Key Companies Time to Begin Mass Production of Drugs for Osteoarthritis Pain
Table 10. Global Drugs for Osteoarthritis Pain Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Drugs for Osteoarthritis Pain Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Drugs for Osteoarthritis Pain Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Drugs for Osteoarthritis Pain Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Drugs for Osteoarthritis Pain Sales Market Share in Value by Type (2020-2025)
Table 17. Global Drugs for Osteoarthritis Pain Sales Market Share in Value by Type (2026-2031)
Table 18. Global Drugs for Osteoarthritis Pain Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Drugs for Osteoarthritis Pain Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Drugs for Osteoarthritis Pain Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Drugs for Osteoarthritis Pain Sales Market Share in Value by Application (2020-2025)
Table 22. Global Drugs for Osteoarthritis Pain Sales Market Share in Value by Application (2026-2031)
Table 23. Global Drugs for Osteoarthritis Pain Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Drugs for Osteoarthritis Pain Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Drugs for Osteoarthritis Pain Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Drugs for Osteoarthritis Pain Sales Value by Region (2020-2025) & (%)
Table 27. Global Drugs for Osteoarthritis Pain Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Drugs for Osteoarthritis Pain Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Drugs for Osteoarthritis Pain Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Drugs for Osteoarthritis Pain Sales Value, (2026-2031) & (US$ Million)
Table 31. Pfizer Basic Information List
Table 32. Pfizer Description and Business Overview
Table 33. Pfizer Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 34. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Pfizer (2020-2025)
Table 35. Pfizer Recent Developments
Table 36. Johnson & Johnson Basic Information List
Table 37. Johnson & Johnson Description and Business Overview
Table 38. Johnson & Johnson Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 39. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Johnson & Johnson (2020-2025)
Table 40. Johnson & Johnson Recent Developments
Table 41. GlaxoSmithKline Basic Information List
Table 42. GlaxoSmithKline Description and Business Overview
Table 43. GlaxoSmithKline Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 44. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of GlaxoSmithKline (2020-2025)
Table 45. GlaxoSmithKline Recent Developments
Table 46. Bayer Basic Information List
Table 47. Bayer Description and Business Overview
Table 48. Bayer Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 49. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Bayer (2020-2025)
Table 50. Bayer Recent Developments
Table 51. Eli Lilly Basic Information List
Table 52. Eli Lilly Description and Business Overview
Table 53. Eli Lilly Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 54. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Eli Lilly (2020-2025)
Table 55. Eli Lilly Recent Developments
Table 56. Novartis Basic Information List
Table 57. Novartis Description and Business Overview
Table 58. Novartis Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 59. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Novartis (2020-2025)
Table 60. Novartis Recent Developments
Table 61. Sanofi Basic Information List
Table 62. Sanofi Description and Business Overview
Table 63. Sanofi Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 64. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Sanofi (2020-2025)
Table 65. Sanofi Recent Developments
Table 66. Horizon Pharma Basic Information List
Table 67. Horizon Pharma Description and Business Overview
Table 68. Horizon Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 69. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Horizon Pharma (2020-2025)
Table 70. Horizon Pharma Recent Developments
Table 71. Abbott Basic Information List
Table 72. Abbott Description and Business Overview
Table 73. Abbott Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 74. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Abbott (2020-2025)
Table 75. Abbott Recent Developments
Table 76. Mylan Basic Information List
Table 77. Mylan Description and Business Overview
Table 78. Mylan Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 79. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Mylan (2020-2025)
Table 80. Mylan Recent Developments
Table 81. Daiichi Sankyo Basic Information List
Table 82. Daiichi Sankyo Description and Business Overview
Table 83. Daiichi Sankyo Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 84. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Daiichi Sankyo (2020-2025)
Table 85. Daiichi Sankyo Recent Developments
Table 86. TEVA Basic Information List
Table 87. TEVA Description and Business Overview
Table 88. TEVA Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 89. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of TEVA (2020-2025)
Table 90. TEVA Recent Developments
Table 91. Almatica Pharma Basic Information List
Table 92. Almatica Pharma Description and Business Overview
Table 93. Almatica Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 94. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Almatica Pharma (2020-2025)
Table 95. Almatica Pharma Recent Developments
Table 96. Astellas Pharma Basic Information List
Table 97. Astellas Pharma Description and Business Overview
Table 98. Astellas Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 99. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Astellas Pharma (2020-2025)
Table 100. Astellas Pharma Recent Developments
Table 101. Tide Pharmaceutical Basic Information List
Table 102. Tide Pharmaceutical Description and Business Overview
Table 103. Tide Pharmaceutical Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 104. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Tide Pharmaceutical (2020-2025)
Table 105. Tide Pharmaceutical Recent Developments
Table 106. Iroko Pharmaceuticals Basic Information List
Table 107. Iroko Pharmaceuticals Description and Business Overview
Table 108. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 109. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Iroko Pharmaceuticals (2020-2025)
Table 110. Iroko Pharmaceuticals Recent Developments
Table 111. Hengrui Pharmaceutical Basic Information List
Table 112. Hengrui Pharmaceutical Description and Business Overview
Table 113. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 114. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Hengrui Pharmaceutical (2020-2025)
Table 115. Hengrui Pharmaceutical Recent Developments
Table 116. Abiogen Pharma Basic Information List
Table 117. Abiogen Pharma Description and Business Overview
Table 118. Abiogen Pharma Drugs for Osteoarthritis Pain Products, Services and Solutions
Table 119. Revenue (US$ Million) in Drugs for Osteoarthritis Pain Business of Abiogen Pharma (2020-2025)
Table 120. Abiogen Pharma Recent Developments
Table 121. Key Raw Materials Lists
Table 122. Raw Materials Key Suppliers Lists
Table 123. Drugs for Osteoarthritis Pain Downstream Customers
Table 124. Drugs for Osteoarthritis Pain Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 128. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Product Picture
Figure 2. Global Drugs for Osteoarthritis Pain Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Drugs for Osteoarthritis Pain Sales Value (2020-2031) & (US$ Million)
Figure 4. Drugs for Osteoarthritis Pain Report Years Considered
Figure 5. Global Drugs for Osteoarthritis Pain Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Drugs for Osteoarthritis Pain Revenue in 2024
Figure 7. Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Oral Picture
Figure 9. Injection Picture
Figure 10. External Picture
Figure 11. Global Drugs for Osteoarthritis Pain Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 12. Global Drugs for Osteoarthritis Pain Sales Value Market Share by Type, 2024 & 2031
Figure 13. Product Picture of Medical Care
Figure 14. Product Picture of Personal Care
Figure 15. Global Drugs for Osteoarthritis Pain Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Drugs for Osteoarthritis Pain Sales Value Market Share by Application, 2024 & 2031
Figure 17. North America Drugs for Osteoarthritis Pain Sales Value (2020-2031) & (US$ Million)
Figure 18. North America Drugs for Osteoarthritis Pain Sales Value by Country (%), 2024 VS 2031
Figure 19. Europe Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 20. Europe Drugs for Osteoarthritis Pain Sales Value by Country (%), 2024 VS 2031
Figure 21. Asia Pacific Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 22. Asia Pacific Drugs for Osteoarthritis Pain Sales Value by Region (%), 2024 VS 2031
Figure 23. South America Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 24. South America Drugs for Osteoarthritis Pain Sales Value by Country (%), 2024 VS 2031
Figure 25. Middle East & Africa Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 26. Middle East & Africa Drugs for Osteoarthritis Pain Sales Value by Country (%), 2024 VS 2031
Figure 27. Key Countries/Regions Drugs for Osteoarthritis Pain Sales Value (%), (2020-2031)
Figure 28. United States Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 29. United States Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 30. United States Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 31. Europe Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 32. Europe Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 33. Europe Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 34. China Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 35. China Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 36. China Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 37. Japan Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 38. Japan Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 39. Japan Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 40. South Korea Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 41. South Korea Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 42. South Korea Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 43. Southeast Asia Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 45. Southeast Asia Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 46. India Drugs for Osteoarthritis Pain Sales Value, (2020-2031) & (US$ Million)
Figure 47. India Drugs for Osteoarthritis Pain Sales Value by Type (%), 2024 VS 2031
Figure 48. India Drugs for Osteoarthritis Pain Sales Value by Application (%), 2024 VS 2031
Figure 49. Drugs for Osteoarthritis Pain Industrial Chain
Figure 50. Drugs for Osteoarthritis Pain Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
